Direct and allosteric inhibition of the FGF2/HSPGs/FGFR1 ternary complex formation by an antiangiogenic, thrombospondin-1-mimic small molecule.
Fibroblast growth factors (FGFs) are recognized targets for the development of therapies against angiogenesis-driven diseases, including cancer. The formation of a ternary complex with the transmembrane tyrosine kinase receptors (FGFRs), and heparan sulphate proteoglycans (HSPGs) is required for FGF...
Guardado en:
Autores principales: | Katiuscia Pagano, Rubben Torella, Chiara Foglieni, Antonella Bugatti, Simona Tomaselli, Lucia Zetta, Marco Presta, Marco Rusnati, Giulia Taraboletti, Giorgio Colombo, Laura Ragona |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/061b20b1ac724c3e97bcd6d72331e2bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Investigating the dynamic aspects of drug-protein recognition through a combination of MD and NMR analyses: implications for the development of protein-protein interaction inhibitors.
por: Massimiliano Meli, et al.
Publicado: (2014) -
Deciphering the complex role of thrombospondin-1 in glioblastoma development
por: Thomas Daubon, et al.
Publicado: (2019) -
Dual Role of Thrombospondin-1 in Flow-Induced Remodeling
por: Céline Grenier, et al.
Publicado: (2021) -
ROLE OF PRO- AND ANTIANGIOGENIC FACTORS IN PLACENTAL DEVELOPMENT
por: D. I. Sokolov, et al.
Publicado: (2014) -
Antiangiogenic properties of nanoparticles: a systematic review
por: Saeed BA, et al.
Publicado: (2019)